AN ACT RELATING TO STATE AFFAIRS AND GOVERNMENT -- THE RHODE ISLAND HEALTH CARE REFORM ACT OF 2004 -- HEALTH INSURANCE OVERSIGHT
Committee recommended measure be held for further study
Email me when HB 7950 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 7950. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would penalize manufacturers whose prescription drugs show price increases not backed by new clinical evidence. It targets companies selling at least $250,000 of the drug in Rhode Island and prevents them from pulling the drug from the market to dodge the penalty. The goal is to curb unjustified drug price growth and protect consumers.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 7950
3 free questions a day, no accountHistory
- 03/24/2026 Committee recommended measure be held for further study
- 03/20/2026 Scheduled for hearing and/or consideration (03/24/2026)
- 02/27/2026 Introduced, referred to House Health & Human Services
Sponsors
- Potter · sponsor
- Ajello
- Cotter
- Donovan
- Giraldo
- Kislak
- McEntee
- McGaw
- Morales
- Read
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 7950 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 7950 freeOr ask your AI assistant about HB 7950 directly:
Add to Claude, ChatGPT or Cursor